Cargando…

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer

BACKGROUND: Progastrin-releasing peptide (ProGRP) is a potential marker for small-cell lung cancer (SCLC) in serum; however, it may be more stable in plasma. We investigated a new plasma assay (ProGRPp) and its usefulness in diagnosing and monitoring SCLC. METHODS: The marker concentrations were det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nisman, Benjamin, Nechushtan, Hovav, Biran, Haim, Peled, Nir, Gantz-Sorotsky, Hadas, Doviner, Victoria, Perelman, Marina, Bar, Jair, Onn, Amir, Uziely, Beatrice, Peretz, Tamar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815781/ https://www.ncbi.nlm.nih.gov/pubmed/26812573 http://dx.doi.org/10.1038/bjc.2016.7

Ejemplares similares

Liquid First Is “Solid” in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing
por: Sehayek, Or, et al.
Publicado: (2022)

Effects of the single nucleotide polymorphism at MDM2 309 on breast cancer patients with/without BRCA1/2 mutations
por: Nechushtan, Hovav, et al.
Publicado: (2009)

Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone
por: Saad, Akram, et al.
Publicado: (2022)

Potential Refinement of Recurrence Score by pSTAT3 Status
por: Grinshpun, Albert, et al.
Publicado: (2022)

Effects of EGFR driver mutations on pathologic regression in resectable locally advanced non-small cell lung cancer treated with neoadjuvant chemoradiation and completion surgery
por: Appel, Sarit, et al.
Publicado: (2023)

Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells
por: Granit Mizrahi, Avital, et al.
Publicado: (2023)

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)
por: Raphael, Ari, et al.
Publicado: (2022)

Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
por: Maoz, Myriam, et al.
Publicado: (2019)

Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
por: Maoz, Myriam, et al.
Publicado: (2020)

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
por: Nisman, B, et al.
Publicado: (2008)

Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients
por: Zick, Aviad, et al.
Publicado: (2017)

Gut microbial signature in lung cancer patients highlights specific taxa as predictors for durable clinical benefit
por: Haberman, Yael, et al.
Publicado: (2023)

Dose escalation of osimertinib for intracranial progression in EGFR mutated non-small-cell lung cancer with brain metastases
por: Goldstein, Iris M, et al.
Publicado: (2020)

Immune-Related Thyroiditis as a Predictor for Survival in Metastatic Renal Cell Carcinoma
por: Sagie, Shira, et al.
Publicado: (2022)

RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
por: Sagie, Shira, et al.
Publicado: (2022)

Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations
por: Arnon, Johnathan, et al.
Publicado: (2023)

Dynamics of Regulatory Networks in Gastrin-Treated Adenocarcinoma Cells
por: Doni Jayavelu, Naresh, et al.
Publicado: (2014)

Role of Nudt2 in Anchorage-Independent Growth and Cell Migration of Human Melanoma
por: Hidmi, Sana’, et al.
Publicado: (2023)

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data
por: Dudnik, Elizabeth, et al.
Publicado: (2021)

Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study
por: Graziadio, Sara, et al.
Publicado: (2018)

Gastrin and Gastric Cancer
por: Waldum, Helge L., et al.
Publicado: (2017)

The Biological Effects of Gastrin
por: Bennett, A.
Publicado: (1968)

Gastrin and Gastric Cancer
por: Smith, Jill P., et al.
Publicado: (2017)

Gastrin and the Moderate Hypergastrinemias
por: Rehfeld, Jens F.
Publicado: (2021)

SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report
por: Arnon, Johnathan, et al.
Publicado: (2021)

Effect of Helicobacter pylori infection on antral gastrin and somatostatin cells and on serum gastrin concentrations
por: Park, Sill Moo, et al.
Publicado: (1999)

PH motifs in PAR(1&2) endow breast cancer growth
por: Kancharla, A., et al.
Publicado: (2015)

Long term follow-up of EGFR mutated NSCLC cases
por: Rennert, Gad, et al.
Publicado: (2020)

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients
por: Horesh, Adi, et al.
Publicado: (2023)

Philosophy for architects
por: Mitrovic, Branko
Publicado: (2011)

The architect's home
Publicado: (2013)

Foucault for architects
por: Fontana-Giusti, Gordana
Publicado: (2013)

Contemporary architects /
Publicado: (1994)

Architecting for Scale
por: Atchison, Lee
Publicado: (2020)

The Leader Architect
por: Grew, Jim
Publicado: (2018)

Azure for Architects
por: Modi, Ritesh
Publicado: (2020)

Contract for the Architect
Publicado: (1955)

Contract to the Architect
Publicado: (1955)

Patkau Architects
Publicado: (1997)

ASML’s architects
por: Raaijmakers, René
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0hjmg2rfqu74beantd41ihbc91